BioPorto A/S (THOXF)
OTCMKTS · Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024

BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of 95.70 million. The enterprise value is 92.24 million.

Market Cap 95.70M
Enterprise Value 92.24M

Important Dates

The next estimated earnings date is Friday, August 15, 2025.

Earnings Date Aug 15, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class 429.66M
Shares Outstanding n/a
Shares Change (YoY) +13.12%
Shares Change (QoQ) -0.04%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 452.53M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 19.17
PB Ratio 15.94
P/TBV Ratio 16.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.75
EV / Sales 17.53
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -7.18

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.25.

Current Ratio 2.23
Quick Ratio 1.87
Debt / Equity 0.25
Debt / EBITDA n/a
Debt / FCF -0.12
Interest Coverage -134.77

Financial Efficiency

Return on equity (ROE) is -197.60% and return on invested capital (ROIC) is -110.28%.

Return on Equity (ROE) -197.60%
Return on Assets (ROA) -75.41%
Return on Invested Capital (ROIC) -110.28%
Return on Capital Employed (ROCE) -182.52%
Revenue Per Employee 103,986
Profits Per Employee -247,968
Employee Count 48
Asset Turnover 0.47
Inventory Turnover 2.67

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +30.91% in the last 52 weeks. The beta is 0.93, so BioPorto's price volatility has been similar to the market average.

Beta (5Y) 0.93
52-Week Price Change +30.91%
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 47.74
Average Volume (20 Days) 46,655

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BioPorto had revenue of 4.99 million and -11.90 million in losses. Loss per share was -0.03.

Revenue 4.99M
Gross Profit 3.23M
Operating Income -12.77M
Pretax Income -13.06M
Net Income -11.90M
EBITDA -12.66M
EBIT -12.77M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 4.76 million in cash and 1.48 million in debt, giving a net cash position of 3.28 million.

Cash & Cash Equivalents 4.76M
Total Debt 1.48M
Net Cash 3.28M
Net Cash Per Share n/a
Equity (Book Value) 6.00M
Book Value Per Share 0.01
Working Capital 4.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.60 million and capital expenditures -248,922, giving a free cash flow of -12.85 million.

Operating Cash Flow -12.60M
Capital Expenditures -248,922
Free Cash Flow -12.85M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 64.64%, with operating and profit margins of -255.86% and -238.46%.

Gross Margin 64.64%
Operating Margin -255.86%
Pretax Margin -261.58%
Profit Margin -238.46%
EBITDA Margin -253.73%
EBIT Margin -255.86%
FCF Margin n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -13.12%
Shareholder Yield n/a
Earnings Yield -12.44%
FCF Yield -13.43%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BioPorto has an Altman Z-Score of 3.08.

Altman Z-Score 3.08
Piotroski F-Score n/a